If the FDA approves aducanumab, I won’t prescribe it – STAT
https://www.statnews.com/2021/05/30/if-the-fda-approves-biogens-alzheimers-treatment-i-wont-prescribe-it/
Is It Time to Start Stopping Aspirin for Stroke Prevention in Afib? | MedPage Today
https://www.medpagetoday.com/opinion/skeptical-cardiologist/81061 With the advent of the newer oral anticoagulants (NOACs) in the last decade that offer better stroke reduction and less bleeding than warfarin, patient-physician discussions should be about taking…
Three F.D.A. Advisers Resign Over Approval of Alzheimer’s Drug – The New York Times
https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html?smid=fb-nytimes&smtyp=cur
6/8/21 MedDir Report
Download Report here MOST Form Review MOST-10-Things-to-Know-v3.pdf (civhc.org)MOST Program – CIVHC.org § Cannot be required for admission. The form is voluntary. Per C.R.S. 15-18.7-108, a healthcare facility shall not require…
FAQs: What you need to know about the Alzheimer’s drug Aduhelm
https://www.statnews.com/2021/06/07/faqs-what-you-need-to-know-about-the-alzheimers-drug-aduhelm/?utm_campaign=rss Alzheimer’s drug controversy -aducanumab (Aduhelm) Decent summary can be found here –> F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works (msn.com) Patient information – It’s a…
CDPHE special edition LTC newsletter
https://drive.google.com/file/d/1CoVbVnd5X6EiJCJGjv2LaLvmYTJe-r9m/view